Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | QTX3046 |
Synonyms | |
Therapy Description |
QTX3046 selectively inhibits KRAS G12D, potentially resulting in decreased cell proliferation and tumor growth (Cancer Res (2023) 83 (8_Supplement): LB321). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
QTX3046 | QTX-3046|QTX 3046 | KRAS G12D Inhibitor 16 | QTX3046 selectively inhibits KRAS G12D, potentially resulting in decreased cell proliferation and tumor growth (Cancer Res (2023) 83 (8_Supplement): LB321). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT06428500 | Phase I | QTX3046 Cetuximab + QTX3046 | QTX3046 in Patients With KRAS G12D Mutations | Recruiting | USA | 0 |